Vaxxinity Inc [NASDAQ: VAXX] loss -43.37% on the last trading session, reaching $0.27 price per share at the time.
If compared to the average trading volume of 451.55K shares, VAXX reached a trading volume of 5781162 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Vaxxinity Inc [VAXX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VAXX shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VAXX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Vaxxinity Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on September 08, 2023. While these analysts kept the previous recommendation, Evercore ISI raised their target price to In-line. The new note on the price target was released on April 27, 2022, representing the official price target for Vaxxinity Inc stock.
The Average True Range (ATR) for Vaxxinity Inc is set at 0.09 The Price to Book ratio for the last quarter was 2.55, with the Price to Cash per share for the same quarter was set at 0.24.
Trading performance analysis for VAXX stock
Vaxxinity Inc [VAXX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -39.57. With this latest performance, VAXX shares dropped by -62.01% in over the last four-week period, additionally sinking by -72.30% over the last 6 months – not to mention a drop of -86.72% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VAXX stock in for the last two-week period is set at 21.52, with the RSI for the last a single of trading hit 16.85, and the three-weeks RSI is set at 26.15 for Vaxxinity Inc [VAXX]. The present Moving Average for the last 50 days of trading for this stock 0.6645, while it was recorded at 0.4137 for the last single week of trading, and 1.2152 for the last 200 days.
Vaxxinity Inc [VAXX]: A deeper dive into fundamental analysis
Vaxxinity Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.89 and a Current Ratio set at 1.89.
An analysis of Institutional ownership at Vaxxinity Inc [VAXX]
The top three institutional holders of VAXX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in VAXX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in VAXX stock with ownership which is approximately 5.8386%.
